Xiaochun Zhang - Qingdao Municipal Hospital, Qingdao University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 22 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Perioperative Toripalimab Plus Chemotherapy for Patients with Resectable Non–Small Cell Lung Cancer

Shun Lü,Wei Zhang,Lin Wu,W. Wang,Peng Zhang,Wentao Fang,Wei Xing,Qixun Chen,Lin Yang,Jiandong Mei,Lijie Tan,Xiaohong Sun,Shidong Xu, Xiaohua Hu, Guohua Yang,Dongliang Yu,Nong Yang,Yuping Chen,Jinlu Shan,Ligang Xing,Hui Tian,Xun Zhang, Ming Zhou,Haohui Fang,Tanxiao Huang,Yunpeng Liu,Minhua Ye,Lejie Cao,Jie Jiang,Xingya Li, Luyi Zhu,Danqing Li,Mingqiang Kang,Aihong Zhong,Ke-Neng Chen,Nan Wu, Qian Sun,Haitao Ma,Kaican Cai,Changli Wang,Gen Lin,Kunshou Zhu,Yu Zhang,Xiaochun Zhang,Hong Hu,Wengang Zhang,Jun Chen,Zhixiong Yang,Xiaosheng Hang,Jian Hu,Yunchao Huang,Zhiye Zhang, Lumin Zhang,Liwei Zhang,Lunxu Liu,Dongmei Lin,Jie Zhang,Gang Chen,Yuan Li,Lei Zhu,Weihua Wang, Wenbo Yu, Dengfeng Cao,Patricia Keegan,Sheng Yao

JAMAno. 3 (2024): 201-201

引用0浏览0引用

Role of YES1 Signaling in Tumor Therapy Resistance

Hai Zhou,Dantong Sun,Junyan Tao,Mingjin Xu,Xiaochun Zhang,Helei Hou

Cancer innovationno. 3 (2023): 210-218

引用0浏览0WOS引用

Anlotinib Enhanced the Efficacy of Pembrolizumab in Refractory or Recurrent High-Grade Serous Ovarian Cancer by Regulating the Tumor Microenvironment (LBA 7)

Xiaochun Zhang,Man Jiang,Tianjun Li,Hongwei Lan,Chenming Ning,Guanqun Wang

Gynecologic oncology (2023): S32-S32

引用0浏览0引用

Efficacy and Safety of Pembrolizumab in Combination with Anlotinib in the Treatment of Refractory or Recurrent High-Grade Serous Ovarian Cancer: A Phase 2 Nonrandomized Clinical Trial

Man Jiang,Tianjun Li,Guanqun Wang,Xiaochun Zhang

Journal of clinical oncology（2022）

引用0浏览0引用

P-86 First-line Nivolumab (NIVO) Plus Chemotherapy (chemo) Vs Chemo in Patients with Advanced Gastric Cancer/gastroesophageal Junction Cancer/esophageal Adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese Subgroup Analysis 2-Year Follow-Up

L. Shen,Y. Bai,X. Lin, W. Li,J. Wang,X. Zhang,H. Pan,C. Bai,L. Bai, Y. Cheng,J. Zhang,H. Zhong,Y. Ba,W. Hu,R. Xu,W. Guo,S. Qin, N. Yang, J. Lu, C. Amaya Chanaga,S. Soleymani, T. Liu

Annals of Oncology（2022）

引用1浏览0引用

Tumor Mutation Burden Analysis in a 5,660 Cancer Patient Cohort Reveals Cancer Type-Specific Mechanisms for High Mutation Burden

Xiaodong Jiao,Xiaochun Zhang,Baodong Qin,Dong Liu,Liang Liu,Jianjiao Ni, Ningyu Zhou,Lingxiang Chen,Liangjun Zhu,Songbing Qin,Jianya Zhou,Xueqin Chen,Aijun Li,Ting Hou,Tengfei Zhang,Shannon Chuai,Yuan-Sheng Zang

Journal of clinical oncology（2019）

引用2浏览0引用

Apatinib in Combination with S-1 As First-Line Treatment in Patients with Advanced Gastric Cancer: A Phase II Clinical Trial

Chuantao Zhang,Zimin Liu,Na Zhou, Jianli Zhang,Jingjuan Zhu,Hongying Lv,Tianjun Li,Helei Hou,Dong Liu,Jing Cong,Man Jiang,Kewei Liu,Zhumei Cui,Yanbing Zhou,Xiaochun Zhang

Journal of clinical oncology（2018）

引用1浏览0引用

A Basket Study of Apatinib Induced Tumour Cavitation and Cea Increase in Multiple Solid Tumours

Man Jiang,Helei Hou,Na Zhou, Hua Zhu,Dong Liu,Jing Cong,Chuantao Zhang,Hongying Lv,Jingjuan Zhu,Tianjun Li,Kewei Liu,Xiaochun Zhang

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2017）

引用0浏览0引用

WITHDRAWN: EGFR Exon 19 Deletion is Associated with Favorable Overall Survival after First-Line Icotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients: a Retrospective, Multiple-Center, Real-World Study

Chuantao Zhang,Helei Hou, Xin Cheng, Dianxia Gong,Ling Yang,Haixin Liu, Wenyong Zhu,Na Zhou,Yan Zhu, Ling Chen, Kewei Liu,Jingjuan Zhu,Hongying Lv,Tianjun Li, Dong Liu,Jing Cong,Man Jiang,Yakun Zhang, Hualong Yu,Hongsheng Yu,Xiaochun Zhang

Oncotargetno. 0 (2017)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn